Chemours (CC) Current Deferred Revenue (2015 - 2021)

Chemours' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $3.0 million for Q4 2021.

• In Q4 2021, Current Deferred Revenue fell 57.14% year-over-year to $3.0 million; the TTM figure through Dec 2021 stood at $3.0 million (down 57.14% YoY), while the FY2021 annual figure was $3.0 million, down 57.14% from the prior year.
• Current Deferred Revenue was $3.0 million for Q4 2021 at Chemours, up from $2.0 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $23.0 million in Q1 2017 to a low of $2.0 million in Q3 2021.
• Historically, Current Deferred Revenue has averaged $7.3 million across 5 years, with a median of $7.0 million in 2019.
• The sharpest annual moves came in 2017 and 2019: Current Deferred Revenue slumped 89.47% in 2017, then surged 60.0% in 2019.
• A 5-year view of Current Deferred Revenue shows it stood at $8.0 million in 2017, then decreased by 25.0% to $6.0 million in 2018, then gained by 16.67% to $7.0 million in 2019, then changed by 0.0% to $7.0 million in 2020, then slumped by 57.14% to $3.0 million in 2021.
• The last three Current Deferred Revenue figures came in at $3.0 million (Q4 2021), $2.0 million (Q3 2021), and $3.0 million (Q2 2021), per Business Quant data.